You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 120 No. 4, April 2002 TABLE OF CONTENTS
  Archives
  •  Online Features
  Epidemiology and Biostatistics
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (39)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Quality of Life
 •Diabetic Retinopathy
 •Articles for Residents
 •Macular Degeneration
 •Alert me on articles by topic

Quality of Life With Visual Acuity Loss From Diabetic Retinopathy and Age-Related Macular Degeneration

Arch Ophthalmol. 2002;120:481-484.

Objective  To compare the quality of life in patients with visual acuity loss occurring secondary to diabetic retinopathy with visual acuity loss occurring secondary to age-related macular degeneration (ARMD).

Methods  Consecutive patients with diabetic retinopathy and ARMD were evaluated using the time trade-off method of utility value analysis. Both groups were stratified according to the degree of visual acuity loss in the better-seeing eye (group 1: 20/20-20/25, group 2: 20/30-20/40, group 3: 20/50-20/100, group 4: <=20/200). Utility values obtained from the patients, once stratified for visual acuity group, were compared with use of the t test and the Mann-Whitney U test. In addition, a 2-way analysis of variance was performed to control for potential confounding variables.

Results  No difference was found between the utility value means of the diabetic retinopathy (n = 333) and ARMD (n = 246) subgroups stratified according to visual acuity levels: group 1, P = .54; group 2, P = .96; group 3, P = .09; and group 4, P = .32. A 2-way analysis of variance demonstrated that, among the variables of ocular disease, sex, age, and visual acuity in the better-seeing eye, only visual acuity was significantly associated with utility values (P = .003).

Conclusions  At similar levels of visual acuity loss, that associated with diabetic retinopathy causes a similar reduction in quality of life to that associated with ARMD. This information has important implications for use in cost-utility analyses of ophthalmic interventions.


Melissa M. Brown, MD, MN, MBA; Gary C. Brown, MD, MBA; Sanjay Sharma, MD, MSc, MBA; Jennifer Landy, MD; Jeff Bakal, MSc
From the Center for Evidence-Based Health Care Economics, Flourtown, Pa (Drs M. M. Brown, G. C. Brown, Sharma, and Landy); the Cataract and Primary Eye Care Service (Dr M. M. Brown) and the Retina Vascular Unit (Dr G. C. Brown), Wills Eye Hospital, Jefferson Medical College, Philadelphia, Pa; and the Cost-Effective Ocular Health Policy Unit, Queens University, Kingston, Ontario (Dr Sharma and Mr Bakal).

Corresponding author and reprints: Melissa M. Brown, MD, MN, MBA, Center for Evidence-Based Health Care Economics, Suite 210, 1107 Bethlehem Pike, Flourtown, PA 19031(e-mail: lissa1011{at}aol.com).


RELATED ARTICLE

Archives of Ophthalmology Reader's Choice: Continuing Medical Education
Arch Ophthalmol. 2002;120(4):527-528.
FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

The effect of comorbidities upon ocular and systemic health-related quality of life
Real et al.
Br. J. Ophthalmol. 2008;92:770-774.
ABSTRACT | FULL TEXT  

Health-Related Quality of Life and Utility in Patients With Age-Related Macular Degeneration
Sahel et al.
Arch Ophthalmol 2007;125:945-951.
ABSTRACT | FULL TEXT  

Quality of life and relative importance: a comparison of time trade-off and conjoint analysis methods in patients with age-related macular degeneration
Aspinall et al.
Br. J. Ophthalmol. 2007;91:766-772.
ABSTRACT | FULL TEXT  

Eye Care in the United States: Do We Deliver to High-Risk People Who Can Benefit Most From It?
Zhang et al.
Arch Ophthalmol 2007;125:411-418.
ABSTRACT | FULL TEXT  

Assessing the Impact of Visual Acuity on Quality of Life in Individuals With Type 2 Diabetes Using the Short Form-36
Clarke et al.
Diabetes Care 2006;29:1506-1511.
ABSTRACT | FULL TEXT  

The Impact of Age-Related Macular Degeneration on Health Status Utility Values
Espallargues et al.
IOVS 2005;46:4016-4023.
ABSTRACT | FULL TEXT  

Cost effectiveness of foldable multifocal intraocular lenses compared to foldable monofocal intraocular lenses for cataract surgery
Dolders et al.
Br. J. Ophthalmol. 2004;88:1163-1168.
ABSTRACT | FULL TEXT  

Cost utility of photodynamic therapy for predominantly classic neovascular age related macular degeneration
Hopley et al.
Br. J. Ophthalmol. 2004;88:982-987.
ABSTRACT | FULL TEXT  

Photodynamic Therapy With Verteporfin for Subfoveal Choroidal Neovascularization in Age-Related Macular Degeneration: Results of an Effectiveness Study
Sharma et al.
Arch Ophthalmol 2004;122:853-856.
ABSTRACT | FULL TEXT  

Cost utility of screening and treatment for early age related macular degeneration with zinc and antioxidants
Hopley et al.
Br. J. Ophthalmol. 2004;88:450-454.
ABSTRACT | FULL TEXT  

Impact of Bilateral Visual Impairment on Health-Related Quality of Life: the Blue Mountains Eye Study
Chia et al.
IOVS 2004;45:71-76.
ABSTRACT | FULL TEXT  

The Effect of an Aerobic Exercise Training Program on Quality of Life in Type 2 Diabetes
Holton et al.
The Diabetes Educator 2003;29:837-846.
ABSTRACT  

Economic Analysis in Eye Disease
Lee and Zhang
Arch Ophthalmol 2003;121:115-116.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2002 American Medical Association. All Rights Reserved.